Aditya Birla Sunlife Life Pharma and Healthcare Fund Normal Growth vs Tata India Pharma and Healthcare Fund Regular Plan IDCW Payout
NAV, returns and costs — not a recommendation.
 Aditya Birla Sunlife Life Pharma and Healthcare Fund Normal Growth |  Tata India Pharma and Healthcare Fund Regular Plan IDCW Payout | |
|---|---|---|
| NAV | ₹36.3 | ₹31.7781 |
| NAV date | 2026-09-29 | 2026-09-29 |
| 1 year | +19.53% | +5.96% |
| 3 year (p.a.) | +19.61% | +16.38% |
| 5 year (p.a.) | +13.05% | +12.24% |
| Expense ratio | 1.94% | 1.84% |
| Fund size | ₹1,102.73 Cr | ₹1386.99 Cr |
| Risk | Very high | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.